Xense
Growth Stage
Meta CT, FIRST In The World. Minimize Time to Diagnosis, Treatment & Wellness
Analytics
Raised: $121,739
Aggregate Commitments $
Platform
Wefunder
Start Date
06/14/2022
Close Date
04/30/2023
Min. Goal
$150,000
Max. Goal
$1,070,000
Min. Investment
$500
Security Type
SAFE
Funding Type
RegCF
Series
Series B
Valuation Cap
$228,000,000
Discount Rate
20%
Rolling Commitments $
Status
Active
Reporting Date
06/25/2022
Days Remaining
309
% of Min. Goal
81%
% of Max. Goal
11%
Likelihood of Max
Avg. Daily Raise
$11,067
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Irvine, Delaware
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Xense, with a valuation of $228 million, is raising funds on Wefunder. The company has developed a revolutionary imaging platform called uTomo that provides MetaCT. uTomo combines plain X-ray and CT scanning to diagnose patients with life-threatening problems at a more rapid rate. MetaCT provided by uTomo is user-friendly, eco-friendly, and provides advanced high-resolution 2D and 3D CT images. Ying Zhao founded Xense in April 2018. The current crowdfunding campaign has a minimum target of $150,000 and a maximum target of $1,070,000. The campaign proceeds will be used for product development, operations, marketing, and payroll.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$5 |
$0 |
|
COGS |
$15,466 |
$0 |
|
Tax |
$2,588 |
$0 |
| ||
| ||
|
Net Income |
$-988,204 |
$-1,021,526 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$13,752 |
$63 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$292,218 |
$122,030 |
|
Short-Term Debt |
$520,086 |
$157,043 |
|
Long-Term Debt |
$861,936 |
$531,943 |
|
Total Liabilities |
$1,382,022 |
$688,986 |
Financials as of: 06/14/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Analyst Report 
Pending Review